Clinical trial
Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction
NCT02426645 is registered in ClinicalTrials.gov with Prof. Dr. Marc-H. Dahlke, Ph. D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction
- Lead sponsor
- Prof. Dr. Marc-H. Dahlke, Ph. D.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- April 30, 2019
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.